Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Guide to Targeting the Endocannabinoid System in Drug Design
Adam Stasiulewicz, Katarzyna Znajdek, Monika Grudzień, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2778-2778
Open Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review
A.M. Martins, Ana Luísa Gomes, Inês Vilas Boas, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 210-210
Open Access | Times Cited: 51
Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism
Pengyun Li, Qiaohong Lin, Shiyang Sun, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 9
Open Access | Times Cited: 45
Decoding the Postulated Entourage Effect of Medicinal Cannabis: What It Is and What It Isn’t
Catalina Christensen, Martin Rose, Claus Cornett, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2323-2323
Open Access | Times Cited: 25
Endocannabinoids in immune regulation and immunopathologies
Oindrila Rahaman, Dipyaman Ganguly
Immunology (2021) Vol. 164, Iss. 2, pp. 242-252
Open Access | Times Cited: 54
Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease – A Systematic Review
Szymon Hryhorowicz, Marta Kaczmarek-Ryś, Aleksandra Zielińska, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 52
Positron Emission Tomography Imaging of the Endocannabinoid System: Opportunities and Challenges in Radiotracer Development
Lu Hou, Jian Rong, Ahmed Haider, et al.
Journal of Medicinal Chemistry (2020) Vol. 64, Iss. 1, pp. 123-149
Open Access | Times Cited: 51
Can Echinacea be a potential candidate to target immunity, inflammation, and infection - The trinity of coronavirus disease 2019
Mohamed Fizur Nagoor Meeran, Hayate Javed, Charu Sharma, et al.
Heliyon (2021) Vol. 7, Iss. 2, pp. e05990-e05990
Open Access | Times Cited: 48
New insights into bisphenols induced obesity in zebrafish (Danio rerio): Activation of cannabinoid receptor CB1
Sinuo Tian, Sen Yan, Zhiyuan Meng, et al.
Journal of Hazardous Materials (2021) Vol. 418, pp. 126100-126100
Closed Access | Times Cited: 48
Cannabinoid Therapeutics in Chronic Neuropathic Pain: From Animal Research to Human Treatment
Raquel Maria Pereira Campos, Andrey F. L. Aguiar, Yolanda Paes-Colli, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 43
Visible‐Light Photoswitchable Benzimidazole Azo‐Arenes as β‐Arrestin2‐Biased Selective Cannabinoid 2 Receptor Agonists
Sophie A. M. Steinmüller, Julia Fender, Marie H. Deventer, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 49
Open Access | Times Cited: 19
Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review
Kuldeep Singh, Bharat Bhushan, Dilip Kumar Chanchal, et al.
Behavioural Neurology (2023) Vol. 2023, pp. 1-17
Open Access | Times Cited: 18
Exploring causal mechanisms of psychosis risk
Dominic Oliver, Edward Chesney, Alexis E. Cullen, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 162, pp. 105699-105699
Open Access | Times Cited: 6
Highly Multiplexed Mass Cytometry Identifies the Immunophenotype in the Skin of Dermatomyositis
Jay Patel, Spandana Maddukuri, Yubin Li, et al.
Journal of Investigative Dermatology (2021) Vol. 141, Iss. 9, pp. 2151-2160
Open Access | Times Cited: 33
(Wh)olistic (E)ndocannabinoidome-Microbiome-Axis Modulation through (N)utrition (WHEN) to Curb Obesity and Related Disorders
Jyoti Sihag, Vincenzo Di Marzo
Lipids in Health and Disease (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 24
Phytocannabinoids: Pharmacological effects, biomedical applications, and worldwide prospection
Ana L.G. de Brito Siqueira, Pedro V.V. Cremasco, Juliana O. Bahú, et al.
Journal of Traditional and Complementary Medicine (2023) Vol. 13, Iss. 6, pp. 575-587
Open Access | Times Cited: 14
Investigating the Protective Effects of Luteolin and Gallic Acid from Luffa acutangula L. (Roxb.) amara (Roxb.) C. B. Clarke. Fruit Pericarp Against Alcohol-Induced Liver Toxicity: Extraction, Bioactivity-Guided Fractionation, Molecular Docking, and Dynamics Studies
Mohan Kalaskar, S. Prabhu, Muniappan Ayyanar, et al.
Journal of Ethnopharmacology (2025), pp. 119377-119377
Closed Access
Cannabidiol attenuates lipid metabolism and induces CB1 receptor-mediated ER stress associated apoptosis in ovarian cancer cells
Xuanhe Fu, Zhixiong Yu, Fang Fang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The role of monocytes and macrophages in idiopathic inflammatory myopathies: insights into pathogenesis and potential targets
Shinji Izuka, Toshihiko Komai, Yumi Tsuchida, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol—A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling
Jakub Jakowiecki, Renata Abel, Urszula Orzeł, et al.
Molecules (2021) Vol. 26, Iss. 9, pp. 2456-2456
Open Access | Times Cited: 29
Phytocannabinoids and Cannabis-Based Products as Alternative Pharmacotherapy in Neurodegenerative Diseases: From Hypothesis to Clinical Practice
Yolanda Paes-Colli, Andrey F. L. Aguiar, Alinny Rosendo Isaac, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 20
Gene expression of the endocannabinoid system in endometrium through menstrual cycle
Keisuke Tanaka, Akwasi Amoako, Sally Mortlock, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 19
Targeting CB1 and GPR55 Endocannabinoid Receptors as a Potential Neuroprotective Approach for Parkinson’s Disease
Eva Martínez‐Pinilla, David Aguinaga, Gemma Navarro, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 8, pp. 5900-5910
Closed Access | Times Cited: 30
CB2 receptor‐selective agonists as candidates for targeting infection, inflammation, and immunity in SARS‐CoV‐2 infections
Mohamed Fizur Nagoor Meeran, Charu Sharma, Sameer N. Goyal, et al.
Drug Development Research (2020) Vol. 82, Iss. 1, pp. 7-11
Open Access | Times Cited: 27
Recent Advances in Endocannabinoid System Targeting for Improved Specificity: Strategic Approaches to Targeted Drug Delivery
Mendhi Henna Dasram, Roderick B. Walker, Sandile M. Khamanga
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13223-13223
Open Access | Times Cited: 16
The Interplay between 2-Arachidonoylglycerol and Anandamide Amidohydrolase in Neuropathy
Iddrisu Ibrahim, Joseph Ayariga, Junhuan Xu, et al.
(2024)
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top